Publications by authors named "Tongyu Tong"

Claim this Profile
C
CDK12-Mediated Phosphorylation of FOXA1 Promotes Prostate Cancer Progression via the MDM2-p53 Axis.
Binyuan Yan, Mengjun Huang, Jinxiang Wang, Hanqi Lei, Tongyu Tong

Research (Wash D C)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOMER3 orchestrates SRC-YAP1 activity that promotes tumor cell growth and antagonizes anti-tumor immunotherapy in prostate cancer.
Tongyu Tong, Hanqi Lei, Mengjun Huang, Zheng Yang, Xuyin Dai

Oncogene· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP1-mediated PARylation of TEAD4 stabilizes the YAP1-TEAD4 complex and promotes growth and immune evasion in breast cancer cells.
Yibo Guo, Gaoqing Song, Hailin Zou, Liangxin Lu, Xuyin Dai, Tongyu Tong

Sci Signal· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3-Mediated Mitophagy.
Mengjun Huang, Hanqi Lei, Tongyu Tong, Hailin Zou, Binyuan Yan

Cell Prolif· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy.
Qiliang Teng, Niu Wang, Hanqi Lei, Tongyu Tong, Yupeng Guan

Cancer Immunol Immunother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional study examining the relationship between the advanced lung cancer inflammation index and prostate cancer.
Mengjun Huang, Qiliang Teng, Dong Ning, Tongyu Tong, Fei Cao

J Health Popul Nutr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acidity-Actuated Polymer/Calcium Phosphate Hybrid Nanomotor (PCaPmotor) for Penetrating Drug Delivery and Synergistic Anticancer Immunotherapy.
Bin Xu, Hanqi Lei, Tongyu Tong, Yupeng Guan, Yiyao Wang

Nano Lett· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hippo signaling modulation and its biological implications in urological malignancies.
Tongyu Tong, Mengjun Huang, Binyuan Yan, Bingbiao Lin, Jiaying Yu

Mol Aspects Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ROS-driven supramolecular nanoparticles exhibiting efficient drug delivery for chemo/Chemodynamic combination therapy for Cancer treatment.
Huikun Chen, Chengyuan Xing, Hanqi Lei, Binyuan Yan, Hao Zhang, Tongyu Tong

J Control Release· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oncogenic roles and clinical implications of YAP/TAZ in breast cancer.
Juan Luo, Hailin Zou, Yibo Guo, Tongyu Tong, Yun Chen

Br J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into the ambivalent role of YAP/TAZ in human cancers.
Juan Luo, Liang Deng, Hailin Zou, Yibo Guo, Tongyu Tong

J Exp Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
Hailin Zou, Juan Luo, Yibo Guo, Tongyu Tong, Yuchen Liu

Cell Mol Life Sci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclodextrin-based supramolecular nanoparticles break the redox balance in chemodynamic therapy-enhanced chemotherapy.
Chengyuan Xing, Huikun Chen, Yupeng Guan, Shiqiang Zhang, Tongyu Tong

J Colloid Interface Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Sonosensitizer Delivery by Redox Sensitive Nanoparticles for Prostate Cancer Sonodynamic Therapy via Amplifying Oxidative Stress and Peroxidation.
Tongyu Tong, Hanqi Lei, Shiqiang Zhang, Donggen Jiang, Yupeng Guan

Adv Healthc Mater· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRC kinase-mediated signaling pathways and targeted therapies in breast cancer.
Juan Luo, Hailin Zou, Yibo Guo, Tongyu Tong, Liping Ye

Breast Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smart dual responsive nanocarriers with reactive oxygen species amplification assisted synergistic chemotherapy against prostate cancer.
Yupeng Guan, Chengyuan Xing, Tongyu Tong, Xinyi Zhang, Jun Li

J Colloid Interface Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual pH- and Glutathione-Responsive CO-Generating Nanodrug Delivery System for Contrast-Enhanced Ultrasonography and Therapy of Prostate Cancer.
Lujing Li, Tongyu Tong, Qiao Ji, Zuofeng Xu, Yupeng Guan

ACS Appl Mater Interfaces· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing Prognostic Value of Skeletal-Related Parameters in Metastatic Castration-Resistant Prostate Cancer on Overall Survival: A Systematic Review and Meta-Analysis of Randomized Controlled Trial.
Tongyu Tong, Hanqi Lei, Yupeng Guan, Xiangwei Yang, Guolong Liao

Front Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
Tongyu Tong, Yupeng Guan, Haiyun Xiong, Liling Wang, Jun Pang

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.
Yupeng Guan, Haiyun Xiong, Yupeng Feng, Guolong Liao, Tongyu Tong

Prostate Cancer Prostatic Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis